Concerns remain that email targeting doesn't work for a one-to-many channel. And critics worry FAST channels create ...
Gov. JB Pritzker says progressive tax plans may not pass by the end of session. But the debate over revenue and proposed cuts ...
However, recently the company has diverged from its peers and has been looking to disrupt the way people work, including ...
Kore.ai launches Artemis, a new enterprise AI agent platform designed to help companies build, govern, and scale AI agents ...
Evaluate hyperscaler AI capex productivity with a multiplier framework, tracking $725 billion spend, supply-chain profits, ...
Healthcare Investors (HQH) offers high-yield healthcare exposure, but a tight NAV discount and payout risks warrant ...
Semiconductor test interface provider Chunghwa Precision Test Tech (CHPT) said its revenue in April 2026 continued to set a new all-time monthly high, driven by rising demand for semiconductor testing ...
Klarna Group reports first-quarter results Thursday before the market opens, with investors scrutinizing whether the buy-now-pay-later provider can sustain growth while managing the credit risks ...
VANCOUVER, BC / ACCESS Newswire / May 20, 2026 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec” or the “Company”) is ...
On May 19, 2026, the Securities and Exchange Commission (SEC) proposed rules that would reduce the current multiple and sometimes ...
Rocket Lab (RKLB 2.41%), launch services and space systems provider, closed Monday at $117.35, up 11.26%. The stock moved higher as investors responded to analyst price target hikes and sustained ...
Hosted on MSN
Record revenue growth and higher test pricing keep Exagen (XGN) in focus despite ongoing losses
Exagen delivered record first-quarter revenue and improved adjusted EBITDA metrics as the autoimmune diagnostics company continued expanding adoption of its AVISE CTD testing platform. ・Exagen Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results